Contraindications for GLP-1 receptor agonists are pancreatitis, family history of medullary thyroid cancer, pancreas or kidney dysfunction, and diabetic retinopathy
GLP-1 treatment starts at a low dose and increases over time
Discover BIKAYALUE GLP-1 Patches with 14-in-1 plant formula
Published research, including studies referenced in NIH literature, shows associations between berberine and glucose management support, GLP-1 pathway activity in animal and some human models, and reductions in fasting glucose readings in controlled research settings
ven om glukagon ofta nmns tillsammans med GLP-1 har det en annan roll i energiregleringen
Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023